Compare BCYC & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCYC | VMD |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.7M | 369.2M |
| IPO Year | 2019 | 2018 |
| Metric | BCYC | VMD |
|---|---|---|
| Price | $4.54 | $9.68 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $13.90 | N/A |
| AVG Volume (30 Days) | ★ 296.1K | 244.4K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.14 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $270,280,000.00 |
| Revenue This Year | N/A | $17.88 |
| Revenue Next Year | N/A | $14.98 |
| P/E Ratio | ★ N/A | $164.00 |
| Revenue Growth | N/A | ★ 20.52 |
| 52 Week Low | $4.24 | $5.93 |
| 52 Week High | $9.36 | $10.18 |
| Indicator | BCYC | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 51.86 |
| Support Level | $4.52 | $9.22 |
| Resistance Level | $5.22 | $10.04 |
| Average True Range (ATR) | 0.17 | 0.34 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 52.38 | 70.86 |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.